Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FTY720 in Relapsing Multiple Sclerosis
NCT00333138Phase 2Completed
- Sponsor
- Novartis
- Start
- May 2003
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 2 trial of fingolimod in multiple sclerosis (MS), sponsored by Novartis. Started May 2003; status: completed.
02
Drugs
fingolimod
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00333138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00333138.